Sidra Medicine, a member of Qatar Foundation, will be hosting the Qatar 8th National Sepsis Symposium on September 13 in partnership with Hamad Medical Corporation (HMC).
The event will bring together national and international healthcare professionals to discuss all aspects of sepsis, including prevention through vaccines, biomarkers and best practices for treatment. The event will be hosted online and in person at Sidra Medicine’s Auditorium.
International speakers include Dr John Bradley, distinguished professor of Infectious Diseases from UC San Diego School of Medicine who will be presenting on the Biomarkers of Sepsis and Dr Abdulelah Alhawsawi, lead from the Eastern Mediterranean Sepsis Alliance.
In addition to experts from Sidra Medicine, speakers from the Ministry of Public Health, the Communicable Disease Centre, HMC and Primary Health Care Corporation will also present sepsis programmes updates in Qatar.
Dr Mohamed Janahi, division chief, Infectious Diseases and chair of the Sepsis programme at Sidra Medicine said: “With 50 million patients affected by sepsis, many survivors face long term consequences. This is a critical topic and our main goal is to actively engage clinical and scientific expertise to enhance healthcare professionals’ knowledge of early detection and immediate treatment of sepsis based on global best practices.”
The symposium will also seek to address the wide-ranging consequences of Sepsis including evidence-based correlation between Covid-19 and sepsis related deaths.
Dr Rasha Ashour, senior attending physician at Sidra Medicine, National Paediatric Sepsis lead and chair of the symposium said, “The pandemic has put sepsis at the forefront as a critical healthcare emergency given that Sepsis remains the main cause of hospital re-admissions and higher healthcare costs. The theme “Stop Sepsis, Save Lives” remains relevant today and our experts from Sidra Medicine along with our partners from across the healthcare spectrum in Qatar will be discussing the national efforts to address Sepsis care as well as the impact of Covid-19.”
“Ministry of Public Health has mandated that sepsis care is one of a few significant health challenges being addressed by inter-professional and multi-disciplinary teams working across the public healthcare sector. The National Sepsis Programme, which includes representatives from HMC, Primary Health Care Corporation and Sidra Medicine, focuses on developing, implementing and monitoring national sepsis management protocols and guidelines to promote high standards of evidenced- based care,” said Dr Abdul Salam Saif, national sepsis programme lead and head of Medicine Critical Care at HMC.
International speakers include Dr John Bradley, distinguished professor of Infectious Diseases from UC San Diego School of Medicine who will be presenting on the Biomarkers of Sepsis and Dr Abdulelah Alhawsawi, lead from the Eastern Mediterranean Sepsis Alliance.
In addition to experts from Sidra Medicine, speakers from the Ministry of Public Health, the Communicable Disease Centre, HMC and Primary Health Care Corporation will also present sepsis programmes updates in Qatar.
Dr Mohamed Janahi, division chief, Infectious Diseases and chair of the Sepsis programme at Sidra Medicine said: “With 50 million patients affected by sepsis, many survivors face long term consequences. This is a critical topic and our main goal is to actively engage clinical and scientific expertise to enhance healthcare professionals’ knowledge of early detection and immediate treatment of sepsis based on global best practices.”
The symposium will also seek to address the wide-ranging consequences of Sepsis including evidence-based correlation between Covid-19 and sepsis related deaths.
Dr Rasha Ashour, senior attending physician at Sidra Medicine, National Paediatric Sepsis lead and chair of the symposium said, “The pandemic has put sepsis at the forefront as a critical healthcare emergency given that Sepsis remains the main cause of hospital re-admissions and higher healthcare costs. The theme “Stop Sepsis, Save Lives” remains relevant today and our experts from Sidra Medicine along with our partners from across the healthcare spectrum in Qatar will be discussing the national efforts to address Sepsis care as well as the impact of Covid-19.”
“Ministry of Public Health has mandated that sepsis care is one of a few significant health challenges being addressed by inter-professional and multi-disciplinary teams working across the public healthcare sector. The National Sepsis Programme, which includes representatives from HMC, Primary Health Care Corporation and Sidra Medicine, focuses on developing, implementing and monitoring national sepsis management protocols and guidelines to promote high standards of evidenced- based care,” said Dr Abdul Salam Saif, national sepsis programme lead and head of Medicine Critical Care at HMC.